New additions to the team!
14 December 2015
A warm welcome to two new team members.
Amanda Portal joins the team as a new Research Associate working on the ROCS (Radiotherapy after Oesophageal Cancer Stenting) study. The aim of this study is to assess the impact of radiotherapy in addition to metal tube/stent placement on swallowing and quality of life in patients with oesophageal cancer who are unable to undergo surgery
Research Assistant Hollie Richards joins us to work on the eRAPID (Electronic patient self-Reporting of Adverse events: Patient Information and aDvice) feasibility study. This study is exploring the feasibility of a new electronic system for patients to self-report adverse events following surgery for upper gastrointestinal cancer.